Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2018-02-05T09:26:29+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

ASX: Dimerix on Channel 7 News

Dimerix's DMX-200 clinical program has been featured on Channel 7 News. Full details are available here. The video is available on [...]

Dimerix clinical studies in the media

Dimerix is pleased to announce coverage of our DMX-200 clinical program in the media. In support of Kidney Week 2018, Channel [...]

ASX announcement: Dimerix raises a further A$4.5M

Dimerix Limited  has raised an additional $4.5 million through the issue of 37,500,000 shares at 12 cents per share to wholesale [...]

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation